Acerus Pharmaceuticals Corporation announced the acceptance of two NATESTO® clinical studies for presentation at the American Urological Association's AUA2020 Scientific Program. The AUA2020 meeting will be held May 15th -­ 18th in Washington, DC. Results of the NATESTO® Spermatogenesis Study have been accepted as a Podium Session, by lead author Thomas Masterson, MD, Urology Fellow in the Department of Urology at the University of Miami School of Medicine. The NATESTO® Spermatogenesis Study has been conducted under the direction of principal investigator Ranjith Ramasamy, MD, Associate Professor and Director of Reproductive Urology, Department of Urology, University of Miami School of Medicine. Additionally, the results of a NATESTO® retrospective analysis being conducted under the supervision of principal investigator Parviz Kavoussi, MD, FACS have been accepted for a Moderated Poster Session.